Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Beam Therapeutics (BEAM) Return on Sales (2019 - 2025)

Beam Therapeutics (BEAM) has disclosed Return on Sales for 7 consecutive years, with 2.14% as the latest value for Q4 2025.

  • Quarterly Return on Sales rose 515.0% to 2.14% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.57% through Dec 2025, up 526.0% year-over-year, with the annual reading at 0.57% for FY2025, 536.0% up from the prior year.
  • Return on Sales for Q4 2025 was 2.14% at Beam Therapeutics, up from 11.62% in the prior quarter.
  • The five-year high for Return on Sales was 2.14% in Q4 2025, with the low at 33399.0% in Q1 2021.
  • Average Return on Sales over 5 years is 2168.74%, with a median of 6.18% recorded in 2023.
  • The sharpest move saw Return on Sales crashed -2877267bps in 2021, then surged 3339004bps in 2022.
  • Over 5 years, Return on Sales stood at 1.27% in 2021, then plummeted by -51bps to 1.91% in 2022, then surged by 124bps to 0.45% in 2023, then crashed by -766bps to 3.01% in 2024, then skyrocketed by 171bps to 2.14% in 2025.
  • According to Business Quant data, Return on Sales over the past three periods came in at 2.14%, 11.62%, and 12.08% for Q4 2025, Q3 2025, and Q2 2025 respectively.